Personalized Follow-Up of QOL in Longitudinal Studies: The example of promising experimental treatment of recurrent Glioblastoma with avelumab and axitinib
- Theuns, P. (Speaker)
- Anne Rogiers (Contributor)
- De Cremer, J. (Contributor)
- Laïla Ben Salama (Contributor)
- Jan Bernheim (Contributor)
- B. Neyns (Contributor)
Activity: Talk or presentation › Talk or presentation at a conference